Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.
By E. Van Cutsem, V. Moiseyenko, S. Tjulandin, A. Majlis, M. Constenla, C. Boni, Adriano Rodrigues, M. Fodor, Y. Chao, E. Voznyi and 2 more. Journal of Clinical Oncology, 2006
1,808 citations recorded by the source corpus.
Subfields: Pulmonary and Respiratory Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/b4056ff22e08c3fb9e5add0f1e17ee35fe332280
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pulmonary and Respiratory Medicine
In Surgery
Citations in the corpus
- Japanese gastric cancer treatment guidelines 2018 (5th edition) (2020, background): “Regarding the triplet regimens, superiority of adding docetaxel to a combination of infusional 5FU and cisplatin was proven in the V325 study [50] conducted in the Western countries.”